Dysautonomia: Symptoms and Treatment
Dysautonomia presents with orthostatic intolerance symptoms (dizziness, palpitations, fatigue, pre-syncope) that worsen upon standing, and treatment should begin immediately with non-pharmacological interventions—increased fluid intake (2-3L daily), salt supplementation (6-10g daily), compression garments, and gradual reconditioning exercise—before considering pharmacotherapy. 1
Core Symptoms
Dysautonomia manifests across multiple organ systems with variable severity:
Cardiovascular Manifestations
- Orthostatic tachycardia: Sustained heart rate increase ≥30 bpm (≥40 bpm if <20 years) or HR ≥120 bpm within 10 minutes of standing 1, 2
- Palpitations and chest discomfort
- Dizziness and lightheadedness
- Pre-syncope or frank syncope 3
Systemic Symptoms
- Profound fatigue and exercise intolerance 4, 3
- Cognitive dysfunction ("brain fog") 3
- Headaches (often positional)
- Heat and cold intolerance 5
- Gastrointestinal symptoms: gastroparesis, constipation, nausea 4
- Genitourinary dysfunction: urinary urgency, bladder overfilling, sexual dysfunction 4, 6
- Post-exertional symptom exacerbation 3
- Sleep disturbances 3
Critical caveat: Symptoms develop acutely (<1 month), subacutely (1-3 months), or insidiously (>3 months), and the tachycardia often represents a compensatory physiological response to impaired venous return rather than primary cardiac pathology 1, 3.
Diagnostic Approach
Essential Clinical Assessment
Measure heart rate and blood pressure supine for ≥5 minutes, then standing for up to 10 minutes. For POTS diagnosis, orthostatic tachycardia must be sustained for ≥2 consecutive recordings (separated by ≥1 minute) after the first minute 1.
During orthostatic vital signs, correlate heart rate increments with patient symptoms—this is diagnostically critical 1.
Initial Laboratory Workup
Perform these tests to identify secondary causes 1:
- Complete blood count
- Electrolytes (Na+, K+, Cl-)
- Renal function (creatinine, urea)
- Ferritin (iron deficiency commonly overlooked)
- Thyroid stimulating hormone
- Morning cortisol level
When to Avoid Extensive Testing
Do NOT routinely order 1:
- Tilt table testing
- Echocardiogram or external ECG monitoring (unless suspecting structural heart disease or non-sinus arrhythmia)
- Autonomic nervous system testing
- Plasma catecholamine levels
- Neuroimaging or EEG (only if focal neurological deficits present)
The guideline explicitly states most patients with POTS will not need these tests 1. Reserve detailed autonomic testing only for patients refractory to initial conventional therapy or when suspecting autonomic neuropathy 1.
Treatment Algorithm
First-Line: Non-Pharmacological Management (MANDATORY FOUNDATION)
These interventions must be implemented before pharmacotherapy 7:
Volume Expansion:
- Fluid intake: 2-3 liters daily
- Salt supplementation: 6-10 grams daily (unless contraindicated)
- Consider 24-hour urine sodium measurement if compliance uncertain 1
Mechanical Countermeasures:
- Lower-body compression stockings (waist-high, 30-40 mmHg)
- Abdominal binders 2
Postural Strategies:
- Sleep with head elevated 20-30 cm (addresses supine hypertension) 2
- Avoid rapid postural changes
- Do not get up at night 2
Dietary Modifications:
- Small, frequent meals (prevents postprandial hypotension)
- Adequate hydration before meals 2
Exercise Reconditioning (CRITICAL):
- Gradual, supervised physical activity
- Emphasize sitting, lying down, or water-based exercise initially 2
- Pacing strategies when post-exertional symptom exacerbation present 3
Second-Line: Pharmacotherapy
Initiate pharmacotherapy only after optimizing non-pharmacological measures and for persistent functional impairment 3.
For Orthostatic Hypotension:
- Fludrocortisone: First-line mineralocorticoid 2
- Midodrine: Alpha-agonist for symptomatic neurogenic orthostatic hypotension 2
- Droxidopa: Norepinephrine precursor (more effective and better tolerated than older agents, though not available in all countries) 4, 2
For Hyperadrenergic POTS:
- Low-dose beta-blockers can be beneficial (whereas excessive doses worsen symptoms) 1
Medications to AVOID:
These can precipitate or worsen dysautonomia 1:
- Alpha-adrenergic blockers
- Excessive beta-blockers
- Calcium channel blockers
- SNRIs (serotonin-norepinephrine reuptake inhibitors)
- MAO inhibitors
- Tricyclic antidepressants
- Phenothiazines
All medications should be systematically reviewed and discontinued if potentially contributory 2.
Managing Supine Hypertension
This occurs in >50% of neurogenic orthostatic hypotension patients and represents a major therapeutic challenge 2:
The immediate risk of orthostatic hypotension takes precedence over later risks of supine hypertension—values >160/90 mmHg are tolerable 2.
For severe cases, use short-acting antihypertensives at bedtime:
- Losartan
- Captopril
- Clonidine
- Nitrate patches 2
Emerging Neuromodulatory Approaches
These show promise but remain experimental or not widely implemented 4:
- Spinal cord stimulators for orthostatic hypotension
- Tibial and sacral nerve stimulators for urinary dysfunction
- Gastric electrical stimulation for gastroparesis
Special Considerations
Post-COVID Dysautonomia
This represents a distributed brain-heart-vascular network disorder requiring mechanistic understanding 3. Management follows the same stepwise approach but emphasizes:
- Patient education about post-exertional symptom exacerbation
- School/work accommodations
- Multidisciplinary care coordination 3
Pediatric Populations
Prioritize functional improvement and early education over medication 7. Emphasize behavioral interventions to promote sustainable recovery without pharmacologic dependence 7.
Common Pitfalls
Over-testing: The guideline strongly recommends against routine extensive autonomic testing—history, physical examination, and orthostatic vital signs suffice for most patients 1
Premature pharmacotherapy: Non-pharmacological interventions are the foundation; medications should augment, not replace, these strategies 7
Misattributing tachycardia to primary cardiac disease: The heart rate elevation is typically compensatory for impaired venous return, not a primary arrhythmia 3
Polypharmacy from multiple subspecialists: This often worsens symptoms rather than improving them 5. Coordinate care centrally and systematically review all medications 2
Ignoring supine hypertension: While concerning, the immediate risks of orthostatic hypotension must take priority 2